Top

Conferences

Dr. Allen’s Research Group

2018

2018 Annual CSPS/CC-CRS Conference

May 2018, Toronto, Canada.

Dunne M., Dou Y., Gontijo S.M.L., Drake D.M., Spence T., Wells P.G., Allen C. Hyperthermia-Mediated Drug Delivery Increases Cisplatin Sensitivity and Accumulation Resulting in Improved Efficacy in Triple Negative Breast Cancer

Poster presentation

2018

International Congress on Targeted Anticancer Therapies (TAT)

Mar 2018, Paris, France.

Houdaihed L., Evans J., Allen C. Delivery of Paclitaxel and Everolimus in Dual-Targeted Polymeric Nanoparticles to Breast Cancer Cells.

Poster presentation

2017

International Conference on Nanomedicine and Nanobiotechnology (ICONAN)

Sep 2017, Barcelona, Spain.

Houdaihed L., Evans J., Allen C. Delivery of Paclitaxel and Everolimus in HER2-Targeted Polymeric Nanoparticles to HER2 Positive Metastatic Breast Cancer.

Poster presentation

2017

Carolina Nanoformulation Workshop/ UNC Eshelman School of Pharmacy

Mar 2017, Capel Hill, North Carolina, USA.

Attendants: Dr. Christine Allen, Loujin Houdaihed and Lucy Wang.

43rd Annual Meeting & Exposition of the Controlled Release Society (CRS)

2016
July  2016, Seattle, USA.

Her S., Cui L., Jaffray D.A., Bristow R.G., Allen C. Cispatin-Conjugated Gold Nanoparticles as a Radiosensitizer for Treatment of Triple Negative Breast Cancer.

Poster presentation and research highlight talk.

2016
July  2016, Seattle, USA.

Dou Y., Chaudary N., Dunne M., Huang H., Jaffray D., Milosevic M., Allen C. Heterogeneity in Cervical Tumor Microenvironment Significantly Impacts the Delivery of a Heat-Activated Thermosensitive Liposome Formulation of Cisplatin.

Poster presentation

2016
July  2016, Seattle, USA.

Dou Y., Dunne M., Huang H., Mckee T., Jaffray D., Allen C. Hyperthermia-Induced Triggered Release of Cisplatin from Thermosensitive Liposomes and Changes in Tumor Microenvironment in Non-Small Cell Lung Carcinoma.

Poster presentation and research highlight talk.

2016
July  2016, Seattle, USA.

Dunne M., Dou Y., Gontijo S.M.L., Spence T., Allen C. Heat-Triggered Release of Cisplatin from Thermosensitive Liposomes Improves Drug Efficacy in Models of Human Triple Negative Breast Cancer.

Poster presentation

2015

NanoDDS, International Nanomedicine & Drug Delivery Symposium

Sep 2015, Seattle, USA.

Her S., Cui L., Jaffray D.A., Bristow R.G., Allen C. Cispatin-Conjugated Gold Nanoparticles as a Radiosensitizer for Treatment of Triple Negative Breast Cancer.

Poster presentation

2015

ESHO / The European Society for Hyperthermic Oncology

June 2015, Zurich, Switzerland.

Dunne M., Dou Y., Gontijo S.M.L., Spence T., Allen C. Heat-Triggered Release of Cisplatin from Thermosensitive Liposomes Improves Drug Efficacy in Models of Human Triple Negative Breast Cancer.

Oral presentation, Recipient of Young Investigator Award.

2015

ESHO / The European Society for Hyperthermic Oncology

June 2015, Zurich, Switzerland.

Dou Y.N., Chaudary N., Dunne M., Jaffray D.A., Milosevic M., Allen C. The Impact of Tumor Microenvironment on Delivery of a Heat-Activated Thermosensitive Liposome Formulation of Cisplatin for Treatment of Cervical Cancer.

Oral presentation

2015

AAPS Annual Meeting & Exposition- National Biotechnology Conference

June 2015, San Francisco, CA, USA.

Dou Y.N., Chaudary N., Dunne M., Jaffray D.A., Milosevic M., Allen C. The Impact of Tumor Microenvironment on Delivery of a Heat-Activated Thermosensitive Liposome Formulation of Cisplatin for Treatment of Cervical Cancer.

Poster presentation. Formulation Design and Development Section Travelship Winner.

2015 Annual CSPS/CC-CRS Conference

2015
May 2015, Toronto, Canada.

Dunne M., Dou Y., Gontijo S.M.L., Spence T., Allen C. Heat-Triggered Release of Cisplatin from Thermosensitive Liposomes Improves Drug Efficacy in Models of Human Triple Negative Breast Cancer.

Poster presentation. Recipient of Poster Award (Second place winner), Canadian Chapter-CRS.

2015
May 2015, Toronto, Canada.

Ekdawi S.N., Stewart J.M.P., Dunne M., Stapleton S., Misakakis N., Dou Y.N., Jaffray D.A., Allen C. Determinants of Liposome Distribution at the Bulk and Intratumoral Levels: Impact of Time, Region and Vascular Density in an Orthotopic tumor model. 

Poster presentation. Recipient of Poster Award (Third place winner), Canadian Chapter-CRS.

2015
May 2015, Toronto, Canada.

Dou Y.N., Chaudary N., Dunne M., Jaffray D.A., Milosevic M., Allen C. The Impact of Tumor Microenvironment on Delivery of a Heat-Activated Thermosensitive Liposome Formulation of Cisplatin for Treatment of Cervical Cancer.​

Poster presentation

2015
May 2015, Toronto, Canada.

Le Devedec F., Oake J., Wong A., Houdaihed L., Yip C., Bohne C., Allen C. Design of Block Copolymer Micelle-Based Drug Formulations using AB Copolymers Synthesized by Living Anionic Polymerization: Effect of Pendant Functional Groups on the Aggregation Behaviour and the Drug Retention.

Poster presentation

2015

International Congress of Radiation Research

May 2015, Kyoto, Japan.

Her S., Cui L., Jaffray D.A., Allen C. Cispatin-Conjugated Gold Nanoparticles as a Radiosensitizer for Treatment of Triple-Negative Breast Cancer.

Poster presentation. Recipient of Young Investigator Travel Award.

2014

Annual Meeting & Exposition of the Controlled Release Society (CRS)

July 2014, Chicago, USA.

De Souza R., Zheng J., Serra S., Francia G., Kerbel R., Allen C., Jaffray D. Multimodal Imaging-Based Characterization of HER2+ and Triple Negative Metastatic Breast Cancer Xenograft Models in Mice.

Oral presentation and poster presentation.

2014

AAPS Annual Meeting & Exposition

May 2014, San Diego, California, USA.

Yannan Dou, Naz Chaudary, Jinzi Zheng, Warren D. Foltz, Robert Weersink, Michael Milosevic, David A. Jaffray, Christine Allen. MR Image-guided Delivery of Cisplatin in Thermosensitive Liposomes (HTLC) Results in Effective Growth Delay in Numerous Xenograft Models of Human Cervical Cancer.

Oral presentation and poster presentation.Recipient of 2014 AAPS Graduate Student Research Award in Formulation Design and Development.

2013

Annual Meeting & Exposition of the Controlled Release Society (CRS)

July 2014, Honolulu, Hawai.

Dou Y., Zheng J., Weersink R., Chaudary N., Foltz W.D., Jaffray D.A., Allen C. Heat-activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice.

Oral presentation and poster presentation.